Molecular Diagnostics
Portable UTI Testing Platform Brings Lab-Quality Molecular Diagnostics to Point-Of-Care Settings
Llusern Scientific is launching its UTI assay panel which can test for up to six urinary tract infections (UTIs) at the point-of-care, revolutionizing the way clinicians test for UTIs. More...25 Apr 2023
Multi-Cancer Blood Test Leverages Machine Learning to Detect and Classify Underlying Disease
A cutting-edge genome-wide methylome enrichment platform has the potential to detect early-stage diseases, thanks to the breadth of information captured through the whole methylome approach. More...21 Apr 2023
Minimally Invasive Blood Test Detects Breast Cancer at Earlier Stages
Breast cancer is the most common cancer globally, with one in eight women developing invasive breast cancer during their lifetime. Now, a blood test for breast cancer screening offers a simple, convenient, and precise method to promote early detection for women. More...20 Apr 2023
Rapid Molecular Diagnostics Platform Uses Multiplex PCR Technology for Fast Diagnosis of Severe Infectious Diseases
A cutting-edge molecular diagnostic platform can reliably and accurately diagnose severe infectious diseases by using multiplex PCR technology to detect a wide range of microorganisms, antibiotic resistance markers, or toxins from sample-to-answer within 4-5 hours. More...20 Apr 2023
Rapid Metagenomics Diagnoses Antibiotic Resistant Bloodstream Infections 18-42 Hours Faster Than Conventional Tests
New research has demonstrated that metagenomic sequencing can offer rapid and actionable AMR predictions for treating bloodstream infections much faster than traditional laboratory tests, potentially saving lives and improving antibiotic management. More...20 Apr 2023
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Homocysteine Quality Control
Liquichek Homocysteine Control
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
In Other News
30-Minute Molecular Assay to Revolutionize Tuberculosis Diagnosis within Near Patient Settings
Novel Reference Materials Meet Needs of Labs Testing for BRCA1/2 Gene Variants
Revolutionary Tests Powered by Exosome-Isolation Technology to Detect Challenging Cancers from Blood Draw
Nanopore-Based Molecular Sensing Technology to Advance Infectious Disease Diagnostics
Clinical RNA Sequencing Platform Can Improve Rare Disease Diagnostics in Pediatrics
Electrochemical Sensor Detects Early-Stage Parkinson’s in Blood Samples
Next Generation Cardiac Control Monitors Precision of Instrument Testing For Cardiac Events
Gastrointestinal PCR Assay Offers Rapid, Culture-Free Pathogen Identification
Novel Testing Method Detects HIV and Hepatitis B/C from Single Drop of Blood
Simple ALS Diagnostic Blood Test Delivers Robust and Reproducible Results
Blood Test Can Predict How Patient’s Cancer Could Grow and Spread
Biological Test Could Be a Game-Changer in Parkinson’s Diagnostics
First and Only Clinically Validated Circulating TTMV DNA Blood Test Detects HPV-Driven Cancer
First-of-Its-Kind Study Establishes Pediatric Reference Intervals for Common Cardiovascular Disease Tests
World’s Most Comprehensive Whole Genome Sequencing Solution Diagnoses Rare and Neurodegenerative Diseases
Blood Test to Measure Sugar Molecule Can Predict Alzheimer’s
Genomic Testing to Help Better Assess and Treat Heart Disease Patients
Next-Generation Diagnostic Test Predicts Drug Responses to Enable More Precise Cancer Therapy
Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care
New Blood Test Identifies Type 2 Diabetes Risk by Analyzing DNA Changes
Breast Cancer Subtyping Assay on Rapid MDx Platform to Deliver Fastest Time to Results
Blood-Based Biomarkers Detectable by Simple Blood Test Could Simplify Diagnosis of Alzheimer's
Benchtop Automated ELISA Platform Achieves Consistent Biomarker Detection
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
